Retroviral DNA Integration: Viral and Cellular Determinants of Target-Site Selection
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Retroviruses differ in their preferences for sites for viral DNA integration in the chromosomes of infected cells. Human immunodeficiency virus (HIV) integrates preferentially within active transcription units, whereas murine leukemia virus (MLV) integrates preferentially near transcription start sites and CpG islands. We investigated the viral determinants of integration-site selection using HIV chimeras with MLV genes substituted for their HIV counterparts. We found that transferring the MLV integrase (IN) coding region into HIV (to make HIVmIN) caused the hybrid to integrate with a specificity close to that of MLV. Addition of MLV gag (to make HIVmGagmIN) further increased the similarity of target-site selection to that of MLV. A chimeric virus with MLV Gag only (HIVmGag) displayed targeting preferences different from that of both HIV and MLV, further implicating Gag proteins in targeting as well as IN. We also report a genome-wide analysis indicating that MLV, but not HIV, favors integration near DNase I-hypersensitive sites (i.e., +/- 1 kb), and that HIVmIN and HIVmGagmIN also favored integration near these features. These findings reveal that IN is the principal viral determinant of integration specificity; they also reveal a new role for Gag-derived proteins, and strengthen models for integration targeting based on tethering of viral IN proteins to host proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Retroviral DNA Integration and the Chimeric Viruses Used in This Study (A) The DNA breaking and joining reactions mediating integration. Gray ovals represent integrase monomers, thick red lines represent viral DNA, black lines represent target DNA, and dots represent 5′ ends. (1) Linear blunt-ended viral cDNA is bound by integrase as part of the preintegration complex. (2) Integrase removes two nucleotides from the 3′ ends of the viral DNA, exposing recessed 3′ hydroxyl groups. (3) IN joins the recessed 3′ ends of viral DNA to the target DNA. (4) Unpairing of the target DNA between the joined ends of the viral DNA yields gaps in the target DNA. (5) DNA repair enzymes fill in the gaps. (6) The provirus is flanked by repeated segments of the target DNA. (B) Chimeric HIV derivatives containing segments of MLV. At the top is the HIV parent virus, with vpr and env inactivated and the puromycin resistance gene in place of nef. Following that are the chimeras, with substitutions of MLV gag gene segments (MA-, p12-, and CA-encoding regions) for HIV MA and CA, or substitution of MLV IN for HIV IN, or both [20,21]. The MLV genome (indicated by an asterisk) is shown for comparison. The MLV used in this study (MLVPuro) was an MLV-based vector (LPCX) encoding the puromycin resistance gene with Gag, Pol, and Env provided in trans. Although we refer to “Gag” in the text, we note that Gag is in fact a polyprotein which is cleaved into individual functional proteins by the action of the viral protease. (C) Target-sequence duplication lengths made by HIV, MLV, and the chimeric viruses. (D) Primary sequences at the site of integration for HIV, MLV, the chimeric viruses, and a previously published MLV dataset (MLV-Burgess). On the x-axis are the top strand positions surrounding the point of integration, which is represented by the blue arrow and line (between positions −1 and 0). For each dataset, the proportion of each base at a given location was divided by the proportion of that base in the matched random control set, such that a base with a y value >1 is present at an increased frequency, while a base with a y value <1 is present at a decreased frequency compared to random sites. A dashed red box surrounds the target sequence that is duplicated upon integration.](https://figures.cochat.ai/paper-figures/05f7d0bde8fb47e2ad42ba2f8a012e93/retroviral-dna-integration-viral-and-cellular-determinants-of-target-site-figure-1.jpg)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, proviral integration in the transcriptionally active regions could potentially favor expression of the viral genes, whereas integration in the transcriptionally silent regions (heterochromatin) may not be in favor of viral expression and may even force the virus to stay transcriptionally silent (Jordan et al. 2001, Lewinski et al. 2006, Einkauf et al. 2022, Teixeira et al. 2024).”
From Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication (2026) · cites this paper as Lewinski et al. 2006
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, it is now becoming clearer that certain retroviruses like HIV tend to target gene-rich, transcriptionally active, euchromatic regions within the host’s chromosome to integrate.”
From Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication (2026) · cites this paper as Lewinski et al. 2006
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, it has been suggested that Gag-derived protein(s), especially CA, plays an important role during retroviral integration.”
From Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication (2026) · cites this paper as Lewinski et al. 2006
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence toward this has been drawn from experiments that have shown that mutations in HIV-1 CA and its interactions with cyclophilin do not inhibit viral integration but favor integration into the genomic regions that are not transcriptionally active, as opposed to wild-type virus typically integrating into the transcriptionally active regions (Lewinski et al. 2006, Schaller et al. 2011, Engelman”
From Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication (2026) · cites this paper as Lewinski et al. 2006
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The gammaretrovirus MLV exhibits preferential insertion near transcriptional start sites, while the lentivirus HIV preferentially inserts within transcriptional units.”
From Clinical use of lentiviral vectors (2018) · cites this paper as [17]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777 · cited 1×
“The integration frequency near CpG islands was then compared. CpG islands are regions rich in the CpG dinucleotide, which are undermethylated and frequently associated with gene regulatory regions [”
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E., Radford, I., Villeval, J.-L., Fraser, C. C., Cavazzana-Calvo, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejm200301163480314 · Cited by 1,867 · cited 1×
“The recent setbacks in human gene-therapy trials, in which a therapeutic retroviral vector integrated near the LMO-2 proto-oncogene and caused leukemia-like illness in three patients [1–3], have focused particular attention on the mechanisms responsible”
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
Self-citationTranscription Start Regions in the Human Genome Are Favored Targets for MLV Integration
Wu, X., Li, Y., Crise, B., & Burgess, S. M. (2003) · Science · doi:10.1126/science.1083413 · Cited by 1,305 · cited 9×
“MLV strongly favors integration near CpG islands while HIV does not [11,14].”
Influential(2007) · Wiley eBooks · doi:10.1128/9781555817954 · Cited by 1,291
NUCLEASE HYPERSENSITIVE SITES IN CHROMATIN
Gross, D. S., & Garrard, W. T. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.001111 · Cited by 1,233
Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences
Mitchell, R. S., Beitzel, B. F., Schroder, A. R. W., Shinn, P., Chen, H., Berry, C. C., Ecker, J. R., & Bushman, F. D. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020234 · Cited by 976
Self-citationIntegration of murine leukemia virus DNA depends on mitosis.
Roe, T., Reynolds, T. C., Yu, G., & Brown, P. O. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05858.x · Cited by 921
Lewis, P. F., & Emerman, M. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.510-516.1994 · Cited by 797
Self-citation
Cited by
Items 101–200 of 415
Chromatin Tethering of Incoming Foamy Virus by the Structural Gag Protein
Tobaly‐Tapiero, J., Bittoun, P., Lehmann‐Che, J., Delelis, O., Giron, M., De Thé, H., & Saïb, A. (2008) · Traffic · doi:10.1111/j.1600-0854.2008.00792.x · Cited by 74
Hackett, C. S., Geurts, A. M., & Hackett, P. B. (2007) · Genome biology · doi:10.1186/gb-2007-8-s1-s12 · Cited by 73
Aiyer, S., Swapna, G. V. T., Malani, N., Aramini, J. M., Schneider, W. M., Plumb, M. R., Ghanem, M., Larue, R. C., Sharma, A., Studamire, B., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku175 · Cited by 72
Self-citationMechanisms of HIV Transcriptional Regulation and Their Contribution to Latency
Lester, G. M. S., & Henderson, A. J. (2012) · Molecular Biology International · doi:10.1155/2012/614120 · Cited by 72
“Gillian M. Schiralli Lester and Andrew J. Henderson Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA Correspondence should be addressed to Andrew J. Henderson, andrew.henderson@bmc.org Received 15 February 2012; Accepted 9 April 2012 Academic Editor: R…”
Impact of repetitive DNA on sex chromosome evolution in plants
Hobza, R., Kubát, Z., Čegan, R., Jesionek, W., Vyskot, B., & Kejnovský, E. (2015) · Chromosome Research · doi:10.1007/s10577-015-9496-2 · Cited by 72
“…evolution in plants 565 this drives insertion upstream of genes (Bridier- Nahmias et al. 2015; Naito et al. 2009) or to specific chromatin locations (Gao et al. 2008; Neumann et al. 2011; Bushman 1994; Bushman and Miller 1997; Bushman et al. 2005; Lewinski et al. 2006; Cherepanov et al. 2011).”
Gammaretroviral Integration into Nucleosomal Target DNA In Vivo
Roth, S. L., Malani, N., & Bushman, F. D. (2011) · Journal of Virology · doi:10.1128/jvi.00635-11 · Cited by 69
“than 1 kb from DNase I-hypersensitive sites (5, 28).”
Self-citationCAR-T cell therapy in ovarian cancer: from the bench to the bedside
Zhu, X., Cai, H., Zhao, L., Ning, L., & Lang, J. (2017) · Oncotarget · doi:10.18632/oncotarget.19929 · Cited by 69
“The genomic integration sites of LVs are not related to promoter regions, which can decrease the risk of meaningful insertional mutagenesis [33, 40].”
Pseudotyping Lentiviral Vectors: When the Clothes Make the Virus
Duvergé, A., & Negroni, M. (2020) · Viruses · doi:10.3390/v12111311 · Cited by 70
“Integration is carried out by the viral enzyme integrase with poor sequence specificity for the selection of the integration sites, although preferential types of genomic regions (as, for example, regions where actively transcribed genes are located, or the proximity with respect to transcription start sites) can be d…”
Rinaldi, G., Eckert, S. E., Tsai, I. J., Suttiprapa, S., Kines, K. J., Tort, J. F., Mann, V. H., Turner, D., Berriman, M., & Brindley, P. J. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002820 · Cited by 68
“of RNA polymerase II driven genes, CpG islands, DNAse I hypersensitive sites and transcription factor binding sites [49].”
Identification of diverse full-length endogenous betaretroviruses in megabats and microbats
Hayward, J. A., Tachedjian, M., Cui, J., Field, H. E., Holmes, E. C., Wang, L., & Tachedjian, G. (2013) · Retrovirology · doi:10.1186/1742-4690-10-35 · Cited by 68
“We attempted to address this question by a comparative analysis of the flanking genomic DNA located immediately up- and downstream of the proviruses and by identifying the TSD that border each provirus and arise as a by-product of the integration mechanism [46].”
Moalic, Y., Blanchard, Y., Felix, H. S., & Jestin, A. (2006) · Journal of Virology · doi:10.1128/jvi.00904-06 · Cited by 67
“(27), who showed that a 15-day selection of HeLA cells resistant to puromycin (after an infection by puromycin-transducing MLV or human immunodeficiency virus [HIV]) had no influence on any of the integration site features except for gene density, a genome feature that will not be considered in this study.”
Rasheedi, S., Shun, M.-C., Serrao, E., Sowd, G. A., Qian, J., Hao, C., Dasgupta, T., Engelman, A. N., & Skowronski, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.721647 · Cited by 65
“Different retrovirus genera show distinct selection preferences for their integration sites, a process guided in part by interactions between components of the viral preintegration complex (PIC) and chromatin targeting proteins (1-4).”
Human Immunodeficiency Virus Integration Efficiency and Site Selection in Quiescent CD4 + T Cells
Vatakis, D. N., Kim, S., Kim, N., Chow, S. A., & Zack, J. A. (2009) · Journal of Virology · doi:10.1128/jvi.00356-09 · Cited by 53
“A series of elegant studies have shown that HIV integration is not tightly sequence specific but not random (8, 12, 14, 15, 23, 37, 38, 47, 51, 54, 79).”
Coffin, J. M., Bale, M. J., Wells, D., Guo, S., Luke, B. T., Zerbato, J. M., Sobolewski, M. D., Sia, T., Shao, W., Wu, X., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009141 · Cited by 63
“As expected [8, 9, 33], the results showed a strong correlation between integration site density and gene expression for all three datasets.”
Kessl, J. J., Li, M., Ignatov, M., Shkriabai, N., Eidahl, J. O., Feng, L., Musier-Forsyth, K., Craigie, R., & Kvaratskhelia, M. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr581 · Cited by 52
Efficient Gene Reframing Therapy for Recessive Dystrophic Epidermolysis Bullosa with CRISPR/Cas9
Takashima, S., Shinkuma, S., Fujita, Y., Nomura, T., Ujiie, H., Natsuga, K., Iwata, H., Nakamura, H., Vorobyev, A., Abe, R., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.02.015 · Cited by 62
Polyclonal fluctuation of lentiviral vector–transduced and expanded murine hematopoietic stem cells
Maetzig, T., Brugman, M. H., Bartels, S., Heinz, N., Kustikova, O. S., Modlich, U., Li, Z., Galla, M., Schiedlmeier, B., Schambach, A., et al. (2011) · Blood · doi:10.1182/blood-2010-08-303222 · Cited by 55
Witting, S. R., Vallanda, P., & Gamble, A. (2013) · Gene Therapy · doi:10.1038/gt.2013.23 · Cited by 61
Ding, D., Qu, X., Li, L., Zhou, X., Liu, S., Lin, S., Wang, P., Liu, S., Kong, C., Wang, X., et al. (2013) · Virology · doi:10.1016/j.virol.2013.02.022 · Cited by 60
“This may be because a transcriptional gene named LEDGF/p75 can induce HIV-1 DNA into the region of actively transcribed genes after interacting directly with viral integrase (Cherepanov et al., 2003; Lewinski et al., 2006; Meehan et al., 2009; Schröder et al., 2002; Vandegraaff et al., 2006).”
Deciphering the Code for Retroviral Integration Target Site Selection
Santoni, F. A., Hartley, O., & Luban, J. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1001008 · Cited by 54
“Integration datasets are generally compared with control datasets using Fisher’s exact test and reported as the p-value [42,43,77,80].”
InfluentialVirophages and retrotransposons colonize the genomes of a heterotrophic flagellate
Hackl, T., Duponchel, S., Barenhoff, K., Weinmann, A., & Fischer, M. G. (2021) · eLife · doi:10.7554/elife.72674 · Cited by 54
Zhao, Z., McKee, C. J., Kessl, J. J., Santos, W. L., Daigle, J. E., Engelman, A., Verdine, G., & Kvaratskhelia, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705241200 · Cited by 49
Williams, D. A., & Thrasher, A. J. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0206 · Cited by 56
LeBlanc, J., Weil, J., & Beemon, K. (2013) · WIREs RNA · doi:10.1002/wrna.1179 · Cited by 47
Romano, G. (2012) · ISRN Oncology · doi:10.5402/2012/616310 · Cited by 41
Weber, B., & Schmidt, T. (2009) · Chromosome Research · doi:10.1007/s10577-009-9029-y · Cited by 55
“Several studies have demonstrated the role of the integrase for different patterns of integrations (Sandmeyer 2003; Zhu et al. 2003; Lewinski et al. 2006).”
Integrase Inhibitors Effective against Human T-Cell Leukemia Virus Type 1
Seegulam, M. E., & Ratner, L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01413-10 · Cited by 54
Host Factors in Retroviral Integration and the Selection of Integration Target Sites
Craigie, R., & Bushman, F. D. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mdna3-0026-2014 · Cited by 45
Self-citationComparative Analysis of the Recently Discovered hAT Transposon TcBuster in Human Cells
Woodard, L. E., Li, X., Malani, N., Kaja, A., Hice, R. H., Atkinson, P. W., Bushman, F. D., Craig, N. L., & Wilson, M. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042666 · Cited by 53
“The transpososomes may be binding to proteins that are present at transcription start sites that enhance their affinity for the DNA, as is the preferred explanation for MLV transcription start site targeting [35], and/or the lack of nucleosomes may enhance integrations at transcription start sites, as is the case for…”
Self-citationThat is life: communicating RNA networks from viruses and cells in continuous interaction
Villarreal, L. P., & Witzany, G. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14040 · Cited by 51
Retroviral Vectors: Post Entry Events and Genomic Alterations
Nowrouzi, A., Glimm, H., Kalle, C. V., & Schmidt, M. (2011) · Viruses · doi:10.3390/v3050429 · Cited by 51
“integrase gene of MLV it has been suggested that the principal viral determinant of retroviral integration specificity is the viral integrase itself [69].”
QuickMap: a public tool for large-scale gene therapy vector insertion site mapping and analysis
Appelt, J.-U., Giordano, F. A., Ecker, M., Roeder, I., Grund, N., Hotz‐Wagenblatt, A., Opelz, G., Zeller, W. J., Allgayer, H., Früehauf, S., et al. (2009) · Gene Therapy · doi:10.1038/gt.2009.37 · Cited by 51
Delivering gene therapy for mucopolysaccharide diseases
Wood, S., & Bigger, B. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.965089 · Cited by 50
“There are three genes that are essential for retroviral function, these are “gag” (encodes structural proteins), “pol” (encodes the reverse transcription machinery for the conversion of viral RNA to pro-viral DNA) and “env” (encodes the envelope glycoproteins) (Lewinski et al., 2006).”
Schneider, W. M., Brzezinski, J. D., Aiyer, S., Malani, N., Gyuricza, M., Bushman, F. D., & Roth, M. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221736110 · Cited by 49
“These results support previous data demonstrating that IN is the dominant factor in defining target-site selection (26).”
Self-citationBoehm, D., & Ott, M. (2017) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2017.0180 · Cited by 49
Delelis, O., Parissi, V., Leh, H., Mbemba, G., Petit, C., Sonigo, P., Deprez, E., & Mouscadet, J. F. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000608 · Cited by 49
Genotoxicity of retroviral hematopoietic stem cell gene therapy
Trobridge, G. D. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.562496 · Cited by 44
“A study that investigated the contribution of the viral integrase to integration site distribution by creating murine leukemia virus MLV-HIV integrase and Gag chimeras showed that the MLV integrase is a major determinant of integration site specificity, but that MLV Gag proteins also can play a role [34].”
Intasome architecture and chromatin density modulate retroviral integration into nucleosome
Benleulmi, M. S., Matysiak, J., Henriquez, D. R., Vaillant, C., Lesbats, P., Calmels, C., Naughtin, M., Leon, O., Skalka, A. M., Ruff, M., et al. (2015) · Retrovirology · doi:10.1186/s12977-015-0145-9 · Cited by 47
“Among all retroviruses, the IN protein and component of the Gag polyprotein have been shown to be involved in integration selectivity [60].”
Epigenetic Regulation of HIV-1 Transcription
Tripathy, M. K., Abbas, W., & Herbein, G. (2011) · Epigenomics · doi:10.2217/epi.11.61 · Cited by 47
Mechanism of random integration of foreign DNA in transgenic mice
Yan, B.-W., Zhao, Y.-F., Cao, W.-G., Li, N., & Gou, K. (2013) · Transgenic Research · doi:10.1007/s11248-013-9701-z · Cited by 46
Methods for integration site distribution analyses in animal cell genomes
Ciuffi, A., Ronen, K., Brady, T., Malani, N., Wang, G., Berry, C. C., & Bushman, F. D. (2009) · Methods · doi:10.1016/j.ymeth.2008.10.028 · Cited by 45
Self-citationNishijima, K., & Iijima, S. (2012) · Development Growth & Differentiation · doi:10.1111/dgd.12032 · Cited by 46
Targeted gene insertion for molecular medicine
Voigt, K., Izsvák, Z., & Ivics, Z. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0381-8 · Cited by 45
“For example, in contrast to MLV, the integration pattern of HIV does not correspond to the genomic distribution of DNaseI hypersensitivity sites that are associated with open chromatin found in regions upstream of genes and in active transcription units [44].”
Mechanisms controlling titer and expression of bidirectional lentiviral and gammaretroviral vectors
Maetzig, T., Galla, M., Brugman, M. H., Loew, R., Baum, C., & Schambach, A. (2009) · Gene Therapy · doi:10.1038/gt.2009.129 · Cited by 45
Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes
Larue, R. C., Plumb, M. R., Crowe, B. L., Shkriabai, N., Sharma, A., DiFiore, J., Malani, N., Aiyer, S. S., Roth, M. J., Bushman, F. D., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku135 · Cited by 44
“The primary viral factor controlling the distribution of retroviral integration sites is integrase (IN), whose key role was demonstrated using a chimeric HIV-1 virus with its IN sequence replaced with the MLV counterpart (3).”
Self-citationBacteriophage Mu integration in yeast and mammalian genomes
Paatero, A., Turakainen, H., Happonen, L., Olsson, C., Palomäki, T., Pajunen, M. I., Meng, X., Otonkoski, T., Tuuri, T., Berry, C. C., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn801 · Cited by 44
“In mammalian cells, several studies of retroviral integration have suggested that proviruses located within gene rich regions are well positioned for gene expression (47,48).”
Self-citationNew insights into stability of recombinant adenovirus vector genomes in mammalian cells
Rauschhuber, C., Noske, N., & Ehrhardt, A. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.01.006 · Cited by 45
Mechanisms of HIV transcriptional regulation by drugs of abuse
Tyagi, M., Bukrinsky, M., & L. Simon, G. (2016) · Current HIV Research · doi:10.2174/1570162x14666160324124736 · Cited by 42
Understanding retroviral life cycle and its genomic RNA packaging
Chameettachal, A., Mustafa, F., & Rizvi, T. A. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167924 · Cited by 41
Henzy, J. E., Gifford, R. J., Johnson, W. E., & Coffin, J. M. (2013) · Journal of Virology · doi:10.1128/jvi.02863-13 · Cited by 41
Brendel, C., Rothe, M., Santilli, G., Charrier, S., Stein, S., Kunkel, H., Abriss, D., Müller-Kuller, U., Gaspar, H. B., Modlich, U., et al. (2018) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2017.245 · Cited by 40
Weber, B., Heitkam, T., Holtgräwe, D., Weißhaar, B., Minoche, A. E., Dohm, J. C., Himmelbauer, H., & Schmidt, T. (2013) · Mobile DNA · doi:10.1186/1759-8753-4-8 · Cited by 40
Lim, K., Klimczak, R. R., Yu, J. H., & Schaffer, D. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001402107 · Cited by 40
Integration of retroviral vectors
Gabriel, R., Schmidt, M., & Kalle, C. V. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.08.006 · Cited by 39
“Substituting IN of a HIV-1 derived lentiviral vector by MLV IN changed the characteristic lentiviral integration pattern into a gammaretroviral-like integration pattern, indicating that the viral IN plays a major role in target site selection [24].”
Saleh, S. M., Lu, H. K., Evans, V. A., Harisson, D., Zhou, J., Jaworowski, A., Sallmann, G. B., Cheong, K., Mota, T. M., Tennakoon, S., et al. (2016) · Retrovirology · doi:10.1186/s12977-016-0284-7 · Cited by 38
“First, in all infection conditions, HIV preferentially integrated in actively transcribed genes (Additional file 4: Figure S4A, B) as previously reported for activated and resting CD4+ T cells [28, 29] and the Jurkat cell line [16].”
Toward Combined Cell and Gene Therapy for Genodermatoses
Rosa, L. D., Latella, M. C., Seconetti, A. S., Cattelani, C., Bauer, J. W., Bondanza, S., & Luca, M. D. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a035667 · Cited by 38
Naughtin, M., Haftek-Terreau, Z., Xavier, J., Meyer, S., Silvain, M., Jaszczyszyn, Y., Levy, N., Miele, V., Benleulmi, M. S., Ruff, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129427 · Cited by 37
“Genomic sequences CL529183, CL529481 and CL528939 [11] and DX598014 [10] of 1.”
Staal, F. J. T., Pike‐Overzet, K., Ng, Y. Y., & van Dongen, J. J. M. (2008) · Leukemia · doi:10.1038/leu.2008.219 · Cited by 37
Possible mechanisms responsible for absence of a retrotransposon family on a plant Y chromosome
Kubát, Z., Žlůvová, J., Vogel, I., Kováčová, V., Čermák, T., Čegan, R., Hobza, R., Vyskot, B., & Kejnovský, E. (2014) · New Phytologist · doi:10.1111/nph.12669 · Cited by 37
Sites of retroviral DNA integration: From basic research to clinical applications
Serrao, E., & Engelman, A. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1102859 · Cited by 36
“…features involved the association of Mo-MLV and ASLV integration with DNase I-hypersensi- tive sites and actively transcribed regions of the genome (Lewinski et al., 2006; Mooslehner et al., 1990; Robinson & Gagnon, 1986; Rohdewohld et al., 1987; Roth et al., 2011; Scherdin et al., 1990; Vijaya…”
Bruce, J. W., Ahlquist, P., & Young, J. A. T. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000207 · Cited by 36
“The data in this report are consistent with either one of two models. In the first model, the sulfonation pathway might influence viral DNA integration site specificity so that when this pathway is impaired, the virus is targeted to regions where the provirus is less transcriptionally competent. This model is consiste…”
Neschadim, A., McCart, J. A., Keating, A., & Medin, J. A. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2007.09.014 · Cited by 36
GS-9822, a Preclinical LEDGIN Candidate, Displays a Block-and-Lock Phenotype in Cell Culture
Bruggemans, A., Vansant, G., Balakrishnan, M., Mitchell, M. L., Cai, R., Christ, F., & Debyser, Z. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02328-20 · Cited by 35
Chick, H. E., Nowrouzi, A., Fronza, R., McDonald, R. A., Kane, N. M., Alba, R., Delles, C., Sessa, W. C., Schmidt, M., Thrasher, A. J., et al. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.042 · Cited by 35
“In particular, the interaction of the LV integration machinery with cellular factors may be responsible for the proposed cell type-and species-specific integration pattern of LV-based vectors (Lewinski et al., 2006; Bartholomae et al., 2011; Biasco et al., 2011; Biasco et al., 2012).”
The genomic risk of somatic gene therapy
Kustikova, O. S., Brugman, M. H., & Baum, C. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.06.003 · Cited by 35
Lentiviral integration preferences in transgenic mice
Yang, S., Cheng, P., Sullivan, R. T., Thomas, J. W., & Chan, A. W. S. (2008) · genesis · doi:10.1002/dvg.20435 · Cited by 35
“Their findings were consistent with the other studies on HIV and MLV integration preference regarding to the CpG islands (Lewinski et al ., 2006; Mitchell et al ., 2004).”
InfluentialThe future of integrase inhibitors of HIV-1
Malet, I., Cálvez, V., & Marcelin, A. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.08.005 · Cited by 33
Genetically engineered immune privileged Sertoli cells: A new road to cell based gene therapy
Kaur, G., Long, C. R., & Dufour, J. M. (2012) · Spermatogenesis · doi:10.4161/spmg.19119 · Cited by 33
“This is a cause for concern since insertion of the gamma-retrovirus is not random but more likely to integrate into transcriptionally active regions of the chromatin.(69,70) No case of insertional mutagenesis has been reported in ADA-SCID trials [another form of SCID, caused by the lack of adenosine deaminase (ADA) en…”
Computational identification of insertional mutagenesis targets for cancer gene discovery
de Jong, J., de Ridder, J., van der Weyden, L., Sun, N., van Uitert, M., Berns, A. J. M., van Lohuizen, M., Jonkers, J., Adams, D. J., & Wessels, L. F. A. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr447 · Cited by 33
Gene silencing in HIV-1 latency by polycomb repressive group
Kim, H. G., Kim, K.-C., Roh, T., Park, J., Jung, K.-M., Lee, J.-S., Choi, S.-Y., Kim, S. S., & Choi, B. (2011) · Virology Journal · doi:10.1186/1743-422x-8-179 · Cited by 33
“Although some reports suggest that the chromatin structure at the HIV1 integration site and LTR region plays a major role in HIV-1 postintegration latency [23,24], the molecular linkage between HIV-1 latency and epigenetic control, especially histone modifications, is not fully understood.”
The effects of cocaine on HIV transcription
Tyagi, M., Weber, J., Bukrinsky, M., & Simon, G. L. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0398-z · Cited by 33
Benleulmi, M. S., Matysiak, J., Robert, X., Miskey, C., Mauro, E., Lapaillerie, D., Lesbats, P., Chaignepain, S., Henríquez, D. R., Calmels, C., et al. (2017) · Retrovirology · doi:10.1186/s12977-017-0378-x · Cited by 33
“Although the IN is a major viral determinant in the integration site selection [2], cellular targeting factors such as BET or LEDGF/p75 proteins, which bind specific histone marks, also contribute to this process by interacting with the IN·viral DNA complex (i.”
Breaking the Silence: Regulation of HIV Transcription and Latency on the Road to a Cure
Duggan, N. N., Dragic, T., Chanda, S. K., & Pache, L. (2023) · Viruses · doi:10.3390/v15122435 · Cited by 32
Compounds producing an effective combinatorial regimen for disruption of HIV‐1 latency
Hashemi, P., Barreto, K., Bernhard, W., Lomness, A., Honson, N. S., Pfeifer, T. A., Harrigan, P. R., & Sadowski, I. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201708193 · Cited by 32
“Compound PH02 reactivates latent HIV-1 integrated at multiple chromosomal locations HIV-1 tends to integrate into actively transcribed regions of the host genome (Jordan et al, 2003; Lewinski et al, 2006; Ikeda et al, 2007).”
Engineered Sleeping Beauty transposase redirects transposon integration away from genes
Miskey, C., Kesselring, L., Querques, I., Abrusán, G., Barábas, O., & Ivics, Z. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac092 · Cited by 32
Genome-Wide Analysis of Alpharetroviral Integration in Human Hematopoietic Stem/Progenitor Cells
Moiani, A., Suerth, J. D., Gandolfi, F., Rizzi, E., Severgnini, M., Bellis, G. D., Schambach, A., & Mavilio, F. (2014) · Genes · doi:10.3390/genes5020415 · Cited by 31
HIV-1 Integrase-DNA Recognition Mechanisms
Kessl, J. J., McKee, C. J., Eidahl, J. O., Shkriabai, N., Katz, A., & Kvaratskhelia, M. (2009) · Viruses · doi:10.3390/v1030713 · Cited by 30
Identifying and retargeting transcriptional hot spots in the human genome
Cheng, J. K., Lewis, A. M., Kim, D. S., Dyess, T. J., & Alper, H. S. (2016) · Biotechnology Journal · doi:10.1002/biot.201600015 · Cited by 29
Desimmie, B. A., Demeulemeester, J., Suchaud, V., Taltynov, O., Billamboz, M., Lion, C. J., Bailly, F., Strelkov, S. V., Debyser, Z., Cotelle, P., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb4000426 · Cited by 28
Meylan, S., Groner, A. C., Ambrosini, G., Malani, N., Quenneville, S., Zangger, N., Kapopoulou, A., Kauzlaric, A., Rougemont, J., Ciuffi, A., et al. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-378 · Cited by 28
“This observation is in agreement with previous data indicating that parental MLV as well as MLV-based gene traps integrate in promoter proximal regions, which are less well annotated than gene bodies, which in turn are the preferential integration sites of LV and LV-based traps [36,37].”
Self-citationChromatin tethering and retroviral integration: Recent discoveries and parallels with DNA viruses
Meehan, A. M., & Poeschla, E. M. (2009) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.10.001 · Cited by 27
“At least for HIV-1 and MLV, the retroviral IN protein appears to confer the integration site preference, with Gag making a lesser contribution [30, 31].”
Retrotransposon Target Site Selection by Imitation of a Cellular Protein
Brady, T., Fuerst, P. G., Dick, R. A., Schmidt, C. L., & Voytas, D. F. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01502-07 · Cited by 27
“(32), and lens epithelium-derived growth factor (LEDGF)/p75,”
The FACT Complex Promotes Avian Leukosis Virus DNA Integration
Winans, S., Larue, R. C., Abraham, C. M., Shkriabai, N., Skopp, A., Winkler, D., Kvaratskhelia, M., & Beemon, K. L. (2017) · Journal of Virology · doi:10.1128/jvi.00082-17 · Cited by 26
Russo, E. M. D. S., Picanço‐Castro, V., Alves, D. C. C., Fernandes, A. C., Almeida-Porada, G. D., Tonn, T., & Covas, D. T. (2010) · Biotechnology Letters · doi:10.1007/s10529-010-0387-5 · Cited by 26
Innate and Adaptive Factors Regulating Human Immunodeficiency Virus Type 1 Genomic Activation
Shah, S., Nonnemacher, M. R., Pirrone, V., & Wigdahl, B. L. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9207-x · Cited by 25
“This has been shown to be true for both resting and activated CD4+ T cells (Barr et al. 2005; Berry et al. 2006; Bushman et al. 2005; Lewinski et al. 2006; Marshall et al. 2007; Mitchell et al. 2004; Wang et al. 2007; Wu et al. 2003).”
Human Immunodeficiency Virus (HIV)-1 Integration Sites in Viral Latency
Rezaei, S. D., & Cameron, P. U. (2015) · Current HIV/AIDS Reports · doi:10.1007/s11904-014-0241-9 · Cited by 25
Zhang, J., Markus, J., Bies, J., Paul, T. A., & Wolff, L. (2012) · Journal of Virology · doi:10.1128/jvi.01077-12 · Cited by 25
“When murine leukemia virus (MLV) site selection is studied in vitro, in the absence of clonal selection, it has been shown that these viruses have preferences not only for the vicinity of the 5= ends but also for insertion within a kilobase of DNase hypersensitivity sites (4, 19).”
Epigenetic control of mobile DNA as an interface between experience and genome change
Shapiro, J. A. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00087 · Cited by 25
Current views on HIV-1 latency, persistence, and cure
Mělková, Z., Shankaran, P., Madlenakova, M., & Bodor, J. (2016) · Folia Microbiologica · doi:10.1007/s12223-016-0474-7 · Cited by 25
“Most commonly, sites of HIV-1 insertion are found in intragenic regions of actively transcribed genes (Lewinski et al. 2006; Serrao and Engelman 2016).”
Westwood, J. A., Murray, W. K., Trivett, M., Shin, A., Neeson, P. J., MacGregor, D. P., Haynes, N. M., Trapani, J. A., Mayura-Guru, P., Fox, S. B., et al. (2008) · Gene Therapy · doi:10.1038/gt.2008.47 · Cited by 25
Hennig, K., Raasch, L., Kolbe, C., Weidner, S., Leisegang, M., Uckert, W., Titeux, M., Hovnanian, A., Kuehlcke, K., & Loew, R. (2014) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2014.083 · Cited by 24
Mechanisms of T-DNA integration
Ziemienowicz, A., Tzfira, T., & Höhn, B. (2007) · Springer eBooks · doi:10.1007/978-0-387-72290-0_11 · Cited by 24
Integration Site and Clonal Expansion in Human Chronic Retroviral Infection and Gene Therapy
Niederer, H. A., & Bangham, C. R. M. (2014) · Viruses · doi:10.3390/v6114140 · Cited by 24
“HIV-based virus containing the integrase of MLV mimicked the MLV integration preference [62].”
The Impact of Cellular Proliferation on the HIV-1 Reservoir
Virgilio, M., & Collins, K. L. (2020) · Viruses · doi:10.3390/v12020127 · Cited by 24
Vranckx, L. S., Demeulemeester, J., Debyser, Z., & Gijsbers, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164167 · Cited by 24
Lierman, E., Miegroet, H. V., Beullens, E., & Cools, J. (2009) · Haematologica · doi:10.3324/haematol.2009.007328 · Cited by 24
Moalic, Y., Félix, H., Takeuchi, Y., Jestin, A., & Blanchard, Y. (2008) · Journal of Virology · doi:10.1128/jvi.00856-08 · Cited by 24
“All of these studies have made it clear that the different retroviral integration profiles observed are a feature of the different retroviral genera and that integration is essentially driven by the virus-encoded integrase (20) via interactions with specific proteins from the host (37) and/or specific DNA structures.”
Cui, P., Löber, U., Alquezar‐Planas, D. E., Ishida, Y., Courtiol, A., Timms, P., Johnson, R. N., Lenz, D., Helgen, K. M., Roca, A. L., et al. (2016) · PeerJ · doi:10.7717/peerj.1847 · Cited by 23
Nasiri, F., Muhammadnejad, S., & Rahbarizadeh, F. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00928-8 · Cited by 22
“Although non-viral delivery methods have been investigated as alternative approaches to the stable expression of CAR molecules on the surface of T cells [43–46], retroviruses and LVs have been utilized more broadly and also as methods in compliance with good manufacturing practice (GMP) [11, 47].”
A point mutation in HIV-1 integrase redirects proviral integration into centromeric repeats
Winans, S., Yu, H. J., Santos, K. D. L., Wang, G. Z., KewalRamani, V. N., & Goff, S. P. (2022) · Nature Communications · doi:10.1038/s41467-022-29097-8 · Cited by 21
Metadata
- Authors
- Lewinski, M. K., Yamashita, M., Emerman, M., Ciuffi, A., Marshall, H., Crawford, G., Collins, F., Shinn, P., Leipzig, J., Hannenhalli, S., Berry, C. C., Ecker, J. R., & Bushman, F. D.
- Affiliations
- Salk Institute for Biological Studies (US)
- Fred Hutch Cancer Center (US)
- University of Pennsylvania (US)
- National Institutes of Health (US)
- University of California San Diego (US)
- Corresponding author
- Bushman, Frederic D
- ORCID
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2006-06-23
- Volume
- 2
- Issue
- 6
- Pages
- e60
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC1480600
- OpenAlex
- W1980869599
- Cited by
- 364
- References
- 46
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 3 · 2023: 5 · 2022: 16 · 2021: 5 · 2020: 9 · 2019: 11 · 2018: 7 · 2017: 18 · 2016: 21 · 2015: 15 · 2014: 26 · 2013: 25 · 2012: 32
- FWCI
- 10.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- James B. Pendleton Charitable Trust
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R37AI030927, AI30927, R56AI030927, AI52845, AI 34786, R01AI034786, R01AI030927, R01AI052845)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- retroviral integration, target site selection, HIV, murine leukemia virus, integrase, Gag protein, chimeric viruses, DNase I hypersensitive sites, CpG islands, transcription start sites, host-virus interaction
- MeSH terms
- Attachment Sites, Microbiological, Binding Sites, Chimera, Cloning, Molecular, Deoxyribonuclease I, DNA, Viral, Glycosaminoglycans, HeLa Cells, HIV, Humans, Leukemia Virus, Murine, Puromycin, Retroviridae, Transcription Factors, Transduction, Genetic, Virus Integration, Gene Transfer Techniques, CpG Islands, Integrases, Transcription Initiation Site
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.